Churchill Management’s VanEck Biotech ETF BBH Stock Holding History

Churchill Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-11,587	Closed	-$1.56M	–	131
2015 Q2	$1.56M	Sell	11,587 -330	-3%	-$43.9K	0.06%	133
2015 Q1	$1.54M	Sell	11,917 -2,728	-19%	-$343K	0.05%	130
2014 Q4	$1.69M	Sell	14,645 -7,227	-33%	-$814K	0.07%	124
2014 Q3	$2.31M	Sell	21,872 -6,674	-23%	-$675K	0.1%	106
2014 Q2	$2.72M	Sell	28,546 -8,986	-24%	-$805K	0.12%	89
2014 Q1	$3.41M	Buy	37,532 +963	+3%	+$93.6K	0.13%	81
2013 Q4	$3.24M	Buy	+36,569	New	+$3.06M	0.12%	61

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

VFAM

Valley Forge Asset Management King Of Prussia, Pennsylvania $645M AUM 5.8% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

LFM

Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return

Churchill Management's BBH Position: Q3 2015 in Review

Churchill Management sold out of VanEck Biotech ETF (BBH) in Q3 2015, closing a stake of 11,587 shares — an estimated $1.56M sold.

Churchill Management first reported a position in BBH in Q4 2013 and held it in 7 quarters. The position peaked at $3.41M in Q1 2014. 83 funds tracked by Wall St. Rank hold BBH as of Q3 2015.

Churchill Management reported no remaining VanEck Biotech ETF position as of Q3 2015 after selling out during the quarter.
Churchill Management sold 11,587 VanEck Biotech ETF shares in Q3 2015, an estimated $1.56M.
Churchill Management first reported a position in VanEck Biotech ETF in Q4 2013 and held it in 7 quarters.
Churchill Management's VanEck Biotech ETF position peaked at $3.41M in Q1 2014.
83 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2015.

Based on Churchill Management's 13F filing for Q3 2015, filed 15 Oct 2015.